These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21193439)

  • 1. Economic impact of remote patient monitoring: an integrated economic model derived from a meta-analysis of randomized controlled trials in heart failure.
    Klersy C; De Silvestri A; Gabutti G; Raisaro A; Curti M; Regoli F; Auricchio A
    Eur J Heart Fail; 2011 Apr; 13(4):450-9. PubMed ID: 21193439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telemonitoring in heart failure.
    Riley JP; Cowie MR
    Heart; 2009 Dec; 95(23):1964-8. PubMed ID: 19923337
    [No Abstract]   [Full Text] [Related]  

  • 3. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
    Caro JJ; Migliaccio-Walle K; O'Brien JA; Nova W; Kim J; Hauch O; Hillson E; Wedel H; Hjalmarson A; Gottlieb S; Deedwania PC; Wikstrand J;
    J Card Fail; 2005 Dec; 11(9):647-56. PubMed ID: 16360958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
    Reed SD; Friedman JY; Velazquez EJ; Gnanasakthy A; Califf RM; Schulman KA
    Am Heart J; 2004 Jul; 148(1):122-8. PubMed ID: 15215801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of remote monitoring of heart failure patients.
    Klersy C; De Silvestri A; Gabutti G; Regoli F; Auricchio A
    J Am Coll Cardiol; 2009 Oct; 54(18):1683-94. PubMed ID: 19850208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost analysis and cost-effectiveness of NT-proBNP-guided heart failure specialist care in addition to home-based nurse care.
    Adlbrecht C; Huelsmann M; Berger R; Moertl D; Strunk G; Oesterle A; Ahmadi R; Szucs T; Pacher R
    Eur J Clin Invest; 2011 Mar; 41(3):315-22. PubMed ID: 21070222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital cost effect of a heart failure disease management program: the Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) trial.
    Gregory D; Kimmelstiel C; Perry K; Parikh A; Konstam V; Konstam MA
    Am Heart J; 2006 May; 151(5):1013-8. PubMed ID: 16644325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study.
    Pulignano G; Del Sindaco D; Di Lenarda A; Tarantini L; Cioffi G; Gregori D; Tinti MD; Monzo L; Minardi G
    J Cardiovasc Med (Hagerstown); 2010 Oct; 11(10):739-47. PubMed ID: 20736784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of valsartan for the treatment of heart-failure patients not receiving ACE inhibitors: a budget impact analysis.
    Smith DG; Cerulli A; Frech FH
    Clin Ther; 2005 Jun; 27(6):951-9. PubMed ID: 16117995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Home monitoring should be the central element in an effective program of heart failure disease management.
    Konstam MA
    Circulation; 2012 Feb; 125(6):820-7. PubMed ID: 22331919
    [No Abstract]   [Full Text] [Related]  

  • 11. Economic impact of heart failure in the United States: time for a different approach.
    O'Connell JB; Bristow MR
    J Heart Lung Transplant; 1994; 13(4):S107-12. PubMed ID: 7947865
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rehabilitation and models of domiciliary care of patients with chronic heart failure. the Gussago experience].
    Zanelli E
    Monaldi Arch Chest Dis; 2005 Jun; 64(2):148-50. PubMed ID: 16499309
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.
    Mullins CD; Rattinger GB; Kuznik A; Koren MJ
    Clin Ther; 2008; 30 Pt 2():2204-16. PubMed ID: 19281915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study.
    Koehler F; Winkler S; Schieber M; Sechtem U; Stangl K; Böhm M; Boll H; Baumann G; Honold M; Koehler K; Gelbrich G; Kirwan BA; Anker SD;
    Circulation; 2011 May; 123(17):1873-80. PubMed ID: 21444883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital costs for treatment of acute heart failure: economic analysis of the REVIVE II study.
    de Lissovoy G; Fraeman K; Teerlink JR; Mullahy J; Salon J; Sterz R; Durtschi A; Padley RJ
    Eur J Health Econ; 2010 Apr; 11(2):185-93. PubMed ID: 19582491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current perspectives in telemonitoring and devices in chronic heart failure patients: lights and shadows].
    Mortara A; Oliva F; Di Lenarda A
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 2):33S-37S. PubMed ID: 20873466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Economic impact of cardiac resynchronization therapy in patients with heart failure. Available evidence and evaluation of the CRT-Eucomed model for analysis of cost-effectiveness].
    Fattore G; Landolina M; Bontempi L; Cacciatore G; Curnis A; Gulizia M; Padeletti L; Mazzei L; Tavazzi L;
    Ital Heart J Suppl; 2005 Dec; 6(12):796-803. PubMed ID: 16444923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost-effectiveness analysis of a peak flow-based asthma education and self-management plan in a high-cost population.
    de Asis ML; Greene R
    J Asthma; 2004 Aug; 41(5):559-65. PubMed ID: 15360065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telehealth. Remote control of care. Monitoring patients with chronic conditions in.
    Moore A
    Health Serv J; 2014 Jun; 124(6401):24-5. PubMed ID: 25046905
    [No Abstract]   [Full Text] [Related]  

  • 20. Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial.
    Al-Khatib SM; Piccini JP; Knight D; Stewart M; Clapp-Channing N; Sanders GD
    J Cardiovasc Electrophysiol; 2010 May; 21(5):545-50. PubMed ID: 20021522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.